Regorafenib Synergizes With TAS102 Against Multiple Gastrointestinal Cancers
July 9, 2024
PRESS RELEASE: On July 2, 2024, a new research paper was published in Oncotarget, entitled, “Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers [...].” continue reading »